To present the experience regarding the epidemiological characteristics and survival of patients who underwent percutaneous endoscopic gastrostomy (PEG) in our unit.

We performed a retrospective analysis of prospectively collected data from patients who underwent PEG placement between (01/06/2019-01/06/2025). Demographic and clinical characteristics, survival (day 28, 3 months, 6 months and overall) and cause of death were recorded. The primary endpoints were the indication for PEG placement, time to death after PEG and death within 3 months following PEG placement.

A total of 119 patients [72 (60.8%) women, mean age 77.7±14.5 years] underwent PEG according to European guidelines indications. The most common indication was dementia-related dysphagia (50.8%), followed by stroke (10.8%) and Parkinson's disease (10.2%). No complications occurred during PEG placement. Overall, survival data (day 28, 3 months and 6 months) were available for 114/119 (95.7%) patients. Median survival time did not differ significantly between indications for PEG placement [135 days 95% CI (37.9-232.1) for dementia, 126 CI95% (39.7-216.2) for stroke and 102 days CI95% (36.1-132.3) for Parkinson's disease, p=0.27). Survival rates at day, 28, 3 months, and 6 months also did not differ significantly across indications for PEG placement (p=0.72, p=0.36, and p=0.31, respectively).

Patient survival after PEG placement does not differ based on the underlying indication for the procedure.